Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011

This cross-sectional study provides a 5-year update on the status and availability of postmarket evidence for high-risk medical devices that received FDA premarket approval in 2010 and 2011.

Detalles Bibliográficos
Autores principales: Rathi, Vinay K., Krumholz, Harlan M., Masoudi, Frederick A., Ross, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455850/
https://www.ncbi.nlm.nih.gov/pubmed/32857145
http://dx.doi.org/10.1001/jamanetworkopen.2020.14496
_version_ 1783575702647341056
author Rathi, Vinay K.
Krumholz, Harlan M.
Masoudi, Frederick A.
Ross, Joseph S.
author_facet Rathi, Vinay K.
Krumholz, Harlan M.
Masoudi, Frederick A.
Ross, Joseph S.
author_sort Rathi, Vinay K.
collection PubMed
description This cross-sectional study provides a 5-year update on the status and availability of postmarket evidence for high-risk medical devices that received FDA premarket approval in 2010 and 2011.
format Online
Article
Text
id pubmed-7455850
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-74558502020-09-03 Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011 Rathi, Vinay K. Krumholz, Harlan M. Masoudi, Frederick A. Ross, Joseph S. JAMA Netw Open Research Letter This cross-sectional study provides a 5-year update on the status and availability of postmarket evidence for high-risk medical devices that received FDA premarket approval in 2010 and 2011. American Medical Association 2020-08-28 /pmc/articles/PMC7455850/ /pubmed/32857145 http://dx.doi.org/10.1001/jamanetworkopen.2020.14496 Text en Copyright 2020 Rathi VK et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Rathi, Vinay K.
Krumholz, Harlan M.
Masoudi, Frederick A.
Ross, Joseph S.
Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
title Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
title_full Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
title_fullStr Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
title_full_unstemmed Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
title_short Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
title_sort postmarket clinical evidence for high-risk therapeutic medical devices receiving food and drug administration premarket approval in 2010 and 2011
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455850/
https://www.ncbi.nlm.nih.gov/pubmed/32857145
http://dx.doi.org/10.1001/jamanetworkopen.2020.14496
work_keys_str_mv AT rathivinayk postmarketclinicalevidenceforhighrisktherapeuticmedicaldevicesreceivingfoodanddrugadministrationpremarketapprovalin2010and2011
AT krumholzharlanm postmarketclinicalevidenceforhighrisktherapeuticmedicaldevicesreceivingfoodanddrugadministrationpremarketapprovalin2010and2011
AT masoudifredericka postmarketclinicalevidenceforhighrisktherapeuticmedicaldevicesreceivingfoodanddrugadministrationpremarketapprovalin2010and2011
AT rossjosephs postmarketclinicalevidenceforhighrisktherapeuticmedicaldevicesreceivingfoodanddrugadministrationpremarketapprovalin2010and2011

Ejemplares similares